nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP1A2—Anagrelide—hematologic cancer	0.0604	0.0887	CbGbCtD
Ramelteon—CYP1A2—Carmustine—hematologic cancer	0.0317	0.0466	CbGbCtD
Ramelteon—CYP2C19—Bortezomib—hematologic cancer	0.0278	0.0408	CbGbCtD
Ramelteon—CYP1A2—Methoxsalen—hematologic cancer	0.027	0.0396	CbGbCtD
Ramelteon—CYP1A2—Bortezomib—hematologic cancer	0.0257	0.0377	CbGbCtD
Ramelteon—CYP1A2—Daunorubicin—hematologic cancer	0.0245	0.036	CbGbCtD
Ramelteon—CYP2C19—Thalidomide—hematologic cancer	0.0242	0.0356	CbGbCtD
Ramelteon—CYP1A2—Alitretinoin—hematologic cancer	0.024	0.0353	CbGbCtD
Ramelteon—CYP2C19—Teniposide—hematologic cancer	0.0231	0.0339	CbGbCtD
Ramelteon—CYP1A2—Thalidomide—hematologic cancer	0.0224	0.0328	CbGbCtD
Ramelteon—CYP3A4—Bexarotene—hematologic cancer	0.0219	0.0322	CbGbCtD
Ramelteon—CYP2C19—Ifosfamide—hematologic cancer	0.0213	0.0313	CbGbCtD
Ramelteon—CYP3A4—Busulfan—hematologic cancer	0.0204	0.0299	CbGbCtD
Ramelteon—CYP3A4—Lomustine—hematologic cancer	0.0204	0.0299	CbGbCtD
Ramelteon—CYP2C19—Imatinib—hematologic cancer	0.0204	0.0299	CbGbCtD
Ramelteon—CYP1A2—Dacarbazine—hematologic cancer	0.0192	0.0282	CbGbCtD
Ramelteon—CYP1A2—Imatinib—hematologic cancer	0.0188	0.0276	CbGbCtD
Ramelteon—CYP3A4—Thiotepa—hematologic cancer	0.0182	0.0267	CbGbCtD
Ramelteon—CYP1A2—Dasatinib—hematologic cancer	0.0151	0.0222	CbGbCtD
Ramelteon—CYP3A4—Methoxsalen—hematologic cancer	0.0141	0.0207	CbGbCtD
Ramelteon—CYP3A4—Bortezomib—hematologic cancer	0.0134	0.0197	CbGbCtD
Ramelteon—CYP2C19—Prednisone—hematologic cancer	0.0134	0.0197	CbGbCtD
Ramelteon—CYP3A4—Daunorubicin—hematologic cancer	0.0129	0.0189	CbGbCtD
Ramelteon—CYP3A4—Cytarabine—hematologic cancer	0.0113	0.0166	CbGbCtD
Ramelteon—CYP3A4—Teniposide—hematologic cancer	0.0112	0.0164	CbGbCtD
Ramelteon—CYP3A4—Ifosfamide—hematologic cancer	0.0103	0.0151	CbGbCtD
Ramelteon—CYP3A4—Imatinib—hematologic cancer	0.00985	0.0145	CbGbCtD
Ramelteon—CYP1A2—Etoposide—hematologic cancer	0.00941	0.0138	CbGbCtD
Ramelteon—CYP3A4—Ruxolitinib—hematologic cancer	0.00928	0.0136	CbGbCtD
Ramelteon—CYP3A4—Nilotinib—hematologic cancer	0.00895	0.0131	CbGbCtD
Ramelteon—CYP3A4—Vinorelbine—hematologic cancer	0.00888	0.013	CbGbCtD
Ramelteon—CYP2C19—Dexamethasone—hematologic cancer	0.00838	0.0123	CbGbCtD
Ramelteon—CYP3A4—Triamcinolone—hematologic cancer	0.00812	0.0119	CbGbCtD
Ramelteon—CYP3A4—Dasatinib—hematologic cancer	0.00791	0.0116	CbGbCtD
Ramelteon—CYP3A4—Mitoxantrone—hematologic cancer	0.00781	0.0115	CbGbCtD
Ramelteon—CYP3A4—Betamethasone—hematologic cancer	0.00697	0.0102	CbGbCtD
Ramelteon—CYP3A4—Prednisolone—hematologic cancer	0.00687	0.0101	CbGbCtD
Ramelteon—CYP3A4—Prednisone—hematologic cancer	0.00649	0.00953	CbGbCtD
Ramelteon—MTNR1A—hematopoietic system—hematologic cancer	0.00637	0.326	CbGeAlD
Ramelteon—CYP3A4—Irinotecan—hematologic cancer	0.00615	0.00903	CbGbCtD
Ramelteon—CYP3A4—Vinblastine—hematologic cancer	0.00547	0.00803	CbGbCtD
Ramelteon—CYP3A4—Vincristine—hematologic cancer	0.00538	0.00789	CbGbCtD
Ramelteon—CYP3A4—Etoposide—hematologic cancer	0.00493	0.00723	CbGbCtD
Ramelteon—MTNR1A—blood—hematologic cancer	0.00422	0.216	CbGeAlD
Ramelteon—CYP3A4—Dexamethasone—hematologic cancer	0.00405	0.00595	CbGbCtD
Ramelteon—MTNR1A—testis—hematologic cancer	0.00349	0.178	CbGeAlD
Ramelteon—CYP3A4—Doxorubicin—hematologic cancer	0.00336	0.00493	CbGbCtD
Ramelteon—CYP2C19—hematopoietic system—hematologic cancer	0.00122	0.0626	CbGeAlD
Ramelteon—CYP1A2—hematopoietic system—hematologic cancer	0.001	0.0512	CbGeAlD
Ramelteon—CYP2C19—blood—hematologic cancer	0.000811	0.0415	CbGeAlD
Ramelteon—CYP3A4—hematopoietic system—hematologic cancer	0.000724	0.037	CbGeAlD
Ramelteon—CYP1A2—blood—hematologic cancer	0.000663	0.0339	CbGeAlD
Ramelteon—CYP1A2—lung—hematologic cancer	0.000581	0.0297	CbGeAlD
Ramelteon—CYP3A4—blood—hematologic cancer	0.00048	0.0245	CbGeAlD
Ramelteon—Asthenia—Cladribine—hematologic cancer	0.000274	0.00154	CcSEcCtD
Ramelteon—Diarrhoea—Chlorambucil—hematologic cancer	0.000273	0.00154	CcSEcCtD
Ramelteon—Headache—Procarbazine—hematologic cancer	0.00027	0.00152	CcSEcCtD
Ramelteon—Myalgia—Vincristine—hematologic cancer	0.000269	0.00151	CcSEcCtD
Ramelteon—Fatigue—Bortezomib—hematologic cancer	0.000268	0.00151	CcSEcCtD
Ramelteon—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000267	0.0015	CcSEcCtD
Ramelteon—Diarrhoea—Nilotinib—hematologic cancer	0.000267	0.0015	CcSEcCtD
Ramelteon—Diarrhoea—Imatinib—hematologic cancer	0.000266	0.0015	CcSEcCtD
Ramelteon—Headache—Bexarotene—hematologic cancer	0.000265	0.00149	CcSEcCtD
Ramelteon—Headache—Dasatinib—hematologic cancer	0.000265	0.00149	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Thiotepa—hematologic cancer	0.000265	0.00149	CcSEcCtD
Ramelteon—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000264	0.00149	CcSEcCtD
Ramelteon—Headache—Fludarabine—hematologic cancer	0.000264	0.00149	CcSEcCtD
Ramelteon—Nausea—Busulfan—hematologic cancer	0.000264	0.00149	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—hematologic cancer	0.000263	0.00148	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Methotrexate—hematologic cancer	0.000263	0.00148	CcSEcCtD
Ramelteon—Asthenia—Vinblastine—hematologic cancer	0.000263	0.00148	CcSEcCtD
Ramelteon—Fatigue—Vinorelbine—hematologic cancer	0.000262	0.00148	CcSEcCtD
Ramelteon—Arthralgia—Mitoxantrone—hematologic cancer	0.000262	0.00147	CcSEcCtD
Ramelteon—Myalgia—Mitoxantrone—hematologic cancer	0.000262	0.00147	CcSEcCtD
Ramelteon—Diarrhoea—Cladribine—hematologic cancer	0.000261	0.00147	CcSEcCtD
Ramelteon—Dizziness—Nilotinib—hematologic cancer	0.000258	0.00145	CcSEcCtD
Ramelteon—Somnolence—Thiotepa—hematologic cancer	0.000258	0.00145	CcSEcCtD
Ramelteon—Anaphylactic shock—Vincristine—hematologic cancer	0.000257	0.00145	CcSEcCtD
Ramelteon—Dizziness—Imatinib—hematologic cancer	0.000257	0.00145	CcSEcCtD
Ramelteon—Nausea—Procarbazine—hematologic cancer	0.000256	0.00144	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Thalidomide—hematologic cancer	0.000256	0.00144	CcSEcCtD
Ramelteon—Myalgia—Gemcitabine—hematologic cancer	0.000255	0.00143	CcSEcCtD
Ramelteon—Arthralgia—Gemcitabine—hematologic cancer	0.000255	0.00143	CcSEcCtD
Ramelteon—Insomnia—Thalidomide—hematologic cancer	0.000254	0.00143	CcSEcCtD
Ramelteon—Dizziness—Cladribine—hematologic cancer	0.000252	0.00142	CcSEcCtD
Ramelteon—Nausea—Bexarotene—hematologic cancer	0.000251	0.00141	CcSEcCtD
Ramelteon—Nausea—Dasatinib—hematologic cancer	0.000251	0.00141	CcSEcCtD
Ramelteon—Anaphylactic shock—Irinotecan—hematologic cancer	0.000251	0.00141	CcSEcCtD
Ramelteon—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000251	0.00141	CcSEcCtD
Ramelteon—Fatigue—Thiotepa—hematologic cancer	0.00025	0.00141	CcSEcCtD
Ramelteon—Nausea—Fludarabine—hematologic cancer	0.00025	0.00141	CcSEcCtD
Ramelteon—Diarrhoea—Vinblastine—hematologic cancer	0.00025	0.00141	CcSEcCtD
Ramelteon—Dysgeusia—Etoposide—hematologic cancer	0.00025	0.00141	CcSEcCtD
Ramelteon—Asthenia—Melphalan—hematologic cancer	0.00025	0.00141	CcSEcCtD
Ramelteon—Somnolence—Thalidomide—hematologic cancer	0.00025	0.00141	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.000246	0.00138	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Carmustine—hematologic cancer	0.000246	0.00138	CcSEcCtD
Ramelteon—Headache—Nilotinib—hematologic cancer	0.000245	0.00138	CcSEcCtD
Ramelteon—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000244	0.00138	CcSEcCtD
Ramelteon—Insomnia—Carmustine—hematologic cancer	0.000244	0.00137	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Alitretinoin—hematologic cancer	0.000243	0.00137	CcSEcCtD
Ramelteon—Headache—Imatinib—hematologic cancer	0.000243	0.00137	CcSEcCtD
Ramelteon—Asthenia—Lenalidomide—hematologic cancer	0.000243	0.00137	CcSEcCtD
Ramelteon—Fatigue—Thalidomide—hematologic cancer	0.000242	0.00136	CcSEcCtD
Ramelteon—Dizziness—Vinblastine—hematologic cancer	0.000242	0.00136	CcSEcCtD
Ramelteon—Insomnia—Alitretinoin—hematologic cancer	0.000242	0.00136	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Ifosfamide—hematologic cancer	0.000241	0.00135	CcSEcCtD
Ramelteon—Somnolence—Carmustine—hematologic cancer	0.00024	0.00135	CcSEcCtD
Ramelteon—Asthenia—Hydroxyurea—hematologic cancer	0.000239	0.00135	CcSEcCtD
Ramelteon—Headache—Cladribine—hematologic cancer	0.000239	0.00135	CcSEcCtD
Ramelteon—Diarrhoea—Melphalan—hematologic cancer	0.000238	0.00134	CcSEcCtD
Ramelteon—Somnolence—Alitretinoin—hematologic cancer	0.000238	0.00134	CcSEcCtD
Ramelteon—Myalgia—Cisplatin—hematologic cancer	0.000238	0.00134	CcSEcCtD
Ramelteon—Nausea—Chlorambucil—hematologic cancer	0.000237	0.00134	CcSEcCtD
Ramelteon—Somnolence—Ifosfamide—hematologic cancer	0.000235	0.00132	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Vincristine—hematologic cancer	0.000235	0.00132	CcSEcCtD
Ramelteon—Depression—Prednisone—hematologic cancer	0.000234	0.00132	CcSEcCtD
Ramelteon—Insomnia—Vincristine—hematologic cancer	0.000233	0.00131	CcSEcCtD
Ramelteon—Nausea—Nilotinib—hematologic cancer	0.000232	0.00131	CcSEcCtD
Ramelteon—Diarrhoea—Lenalidomide—hematologic cancer	0.000232	0.0013	CcSEcCtD
Ramelteon—Nausea—Imatinib—hematologic cancer	0.000231	0.0013	CcSEcCtD
Ramelteon—Fatigue—Alitretinoin—hematologic cancer	0.00023	0.0013	CcSEcCtD
Ramelteon—Headache—Vinblastine—hematologic cancer	0.000229	0.00129	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	0.000228	0.00129	CcSEcCtD
Ramelteon—Diarrhoea—Hydroxyurea—hematologic cancer	0.000228	0.00129	CcSEcCtD
Ramelteon—Fatigue—Ifosfamide—hematologic cancer	0.000228	0.00128	CcSEcCtD
Ramelteon—Anaphylactic shock—Cisplatin—hematologic cancer	0.000228	0.00128	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.000227	0.00128	CcSEcCtD
Ramelteon—Dysgeusia—Triamcinolone—hematologic cancer	0.000227	0.00128	CcSEcCtD
Ramelteon—Insomnia—Irinotecan—hematologic cancer	0.000227	0.00128	CcSEcCtD
Ramelteon—Nausea—Cladribine—hematologic cancer	0.000227	0.00128	CcSEcCtD
Ramelteon—Dizziness—Lenalidomide—hematologic cancer	0.000224	0.00126	CcSEcCtD
Ramelteon—Asthenia—Bortezomib—hematologic cancer	0.000223	0.00126	CcSEcCtD
Ramelteon—Somnolence—Mitoxantrone—hematologic cancer	0.000223	0.00126	CcSEcCtD
Ramelteon—Somnolence—Irinotecan—hematologic cancer	0.000223	0.00126	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	0.000223	0.00125	CcSEcCtD
Ramelteon—Fatigue—Vincristine—hematologic cancer	0.000222	0.00125	CcSEcCtD
Ramelteon—Asthenia—Bleomycin—hematologic cancer	0.000222	0.00125	CcSEcCtD
Ramelteon—Insomnia—Gemcitabine—hematologic cancer	0.000221	0.00124	CcSEcCtD
Ramelteon—Dizziness—Hydroxyurea—hematologic cancer	0.000221	0.00124	CcSEcCtD
Ramelteon—Asthenia—Vinorelbine—hematologic cancer	0.000218	0.00123	CcSEcCtD
Ramelteon—Nausea—Vinblastine—hematologic cancer	0.000217	0.00122	CcSEcCtD
Ramelteon—Somnolence—Gemcitabine—hematologic cancer	0.000217	0.00122	CcSEcCtD
Ramelteon—Fatigue—Irinotecan—hematologic cancer	0.000216	0.00122	CcSEcCtD
Ramelteon—Fatigue—Mitoxantrone—hematologic cancer	0.000216	0.00122	CcSEcCtD
Ramelteon—Diarrhoea—Bortezomib—hematologic cancer	0.000213	0.0012	CcSEcCtD
Ramelteon—Headache—Lenalidomide—hematologic cancer	0.000212	0.00119	CcSEcCtD
Ramelteon—Fatigue—Gemcitabine—hematologic cancer	0.000211	0.00119	CcSEcCtD
Ramelteon—Headache—Hydroxyurea—hematologic cancer	0.000209	0.00118	CcSEcCtD
Ramelteon—Anaphylactic shock—Etoposide—hematologic cancer	0.000209	0.00117	CcSEcCtD
Ramelteon—Asthenia—Thiotepa—hematologic cancer	0.000208	0.00117	CcSEcCtD
Ramelteon—Diarrhoea—Vinorelbine—hematologic cancer	0.000208	0.00117	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000207	0.00117	CcSEcCtD
Ramelteon—Nausea—Melphalan—hematologic cancer	0.000207	0.00116	CcSEcCtD
Ramelteon—Dizziness—Bortezomib—hematologic cancer	0.000206	0.00116	CcSEcCtD
Ramelteon—Anaphylactic shock—Prednisolone—hematologic cancer	0.000206	0.00116	CcSEcCtD
Ramelteon—Influenza—Epirubicin—hematologic cancer	0.000206	0.00116	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Methotrexate—hematologic cancer	0.000204	0.00115	CcSEcCtD
Ramelteon—Asthenia—Thalidomide—hematologic cancer	0.000202	0.00113	CcSEcCtD
Ramelteon—Dizziness—Vinorelbine—hematologic cancer	0.000201	0.00113	CcSEcCtD
Ramelteon—Nausea—Lenalidomide—hematologic cancer	0.000201	0.00113	CcSEcCtD
Ramelteon—Diarrhoea—Thiotepa—hematologic cancer	0.000199	0.00112	CcSEcCtD
Ramelteon—Nausea—Hydroxyurea—hematologic cancer	0.000198	0.00112	CcSEcCtD
Ramelteon—Myalgia—Triamcinolone—hematologic cancer	0.000197	0.00111	CcSEcCtD
Ramelteon—Depression—Methotrexate—hematologic cancer	0.000195	0.0011	CcSEcCtD
Ramelteon—Headache—Bortezomib—hematologic cancer	0.000195	0.0011	CcSEcCtD
Ramelteon—Asthenia—Carmustine—hematologic cancer	0.000194	0.00109	CcSEcCtD
Ramelteon—Diarrhoea—Thalidomide—hematologic cancer	0.000192	0.00108	CcSEcCtD
Ramelteon—Dizziness—Thiotepa—hematologic cancer	0.000192	0.00108	CcSEcCtD
Ramelteon—Asthenia—Alitretinoin—hematologic cancer	0.000192	0.00108	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000191	0.00108	CcSEcCtD
Ramelteon—Headache—Vinorelbine—hematologic cancer	0.00019	0.00107	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—hematologic cancer	0.00019	0.00107	CcSEcCtD
Ramelteon—Asthenia—Ifosfamide—hematologic cancer	0.000189	0.00107	CcSEcCtD
Ramelteon—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000189	0.00107	CcSEcCtD
Ramelteon—Insomnia—Prednisolone—hematologic cancer	0.000186	0.00105	CcSEcCtD
Ramelteon—Dizziness—Thalidomide—hematologic cancer	0.000186	0.00105	CcSEcCtD
Ramelteon—Somnolence—Etoposide—hematologic cancer	0.000185	0.00104	CcSEcCtD
Ramelteon—Nausea—Bortezomib—hematologic cancer	0.000185	0.00104	CcSEcCtD
Ramelteon—Asthenia—Vincristine—hematologic cancer	0.000185	0.00104	CcSEcCtD
Ramelteon—Diarrhoea—Carmustine—hematologic cancer	0.000185	0.00104	CcSEcCtD
Ramelteon—Nausea—Bleomycin—hematologic cancer	0.000184	0.00103	CcSEcCtD
Ramelteon—Diarrhoea—Alitretinoin—hematologic cancer	0.000183	0.00103	CcSEcCtD
Ramelteon—Headache—Thiotepa—hematologic cancer	0.000182	0.00102	CcSEcCtD
Ramelteon—Diarrhoea—Ifosfamide—hematologic cancer	0.000181	0.00102	CcSEcCtD
Ramelteon—Nausea—Vinorelbine—hematologic cancer	0.000181	0.00102	CcSEcCtD
Ramelteon—Asthenia—Mitoxantrone—hematologic cancer	0.00018	0.00101	CcSEcCtD
Ramelteon—Asthenia—Irinotecan—hematologic cancer	0.00018	0.00101	CcSEcCtD
Ramelteon—Fatigue—Etoposide—hematologic cancer	0.00018	0.00101	CcSEcCtD
Ramelteon—Myalgia—Betamethasone—hematologic cancer	0.000179	0.00101	CcSEcCtD
Ramelteon—Myalgia—Dexamethasone—hematologic cancer	0.000179	0.00101	CcSEcCtD
Ramelteon—Dizziness—Carmustine—hematologic cancer	0.000178	0.001	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000177	0.000996	CcSEcCtD
Ramelteon—Dizziness—Alitretinoin—hematologic cancer	0.000177	0.000995	CcSEcCtD
Ramelteon—Diarrhoea—Vincristine—hematologic cancer	0.000176	0.000992	CcSEcCtD
Ramelteon—Headache—Thalidomide—hematologic cancer	0.000176	0.000991	CcSEcCtD
Ramelteon—Asthenia—Gemcitabine—hematologic cancer	0.000175	0.000987	CcSEcCtD
Ramelteon—Dizziness—Ifosfamide—hematologic cancer	0.000175	0.000983	CcSEcCtD
Ramelteon—Nausea—Thiotepa—hematologic cancer	0.000172	0.000971	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000172	0.00097	CcSEcCtD
Ramelteon—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000172	0.000967	CcSEcCtD
Ramelteon—Anaphylactic shock—Betamethasone—hematologic cancer	0.000172	0.000967	CcSEcCtD
Ramelteon—Diarrhoea—Mitoxantrone—hematologic cancer	0.000172	0.000966	CcSEcCtD
Ramelteon—Diarrhoea—Irinotecan—hematologic cancer	0.000172	0.000966	CcSEcCtD
Ramelteon—Insomnia—Triamcinolone—hematologic cancer	0.000171	0.000963	CcSEcCtD
Ramelteon—Dizziness—Vincristine—hematologic cancer	0.00017	0.000959	CcSEcCtD
Ramelteon—Headache—Carmustine—hematologic cancer	0.000169	0.000951	CcSEcCtD
Ramelteon—Headache—Alitretinoin—hematologic cancer	0.000167	0.000943	CcSEcCtD
Ramelteon—Diarrhoea—Gemcitabine—hematologic cancer	0.000167	0.000941	CcSEcCtD
Ramelteon—Nausea—Thalidomide—hematologic cancer	0.000167	0.000939	CcSEcCtD
Ramelteon—Dizziness—Irinotecan—hematologic cancer	0.000166	0.000934	CcSEcCtD
Ramelteon—Asthenia—Cisplatin—hematologic cancer	0.000163	0.00092	CcSEcCtD
Ramelteon—Fatigue—Triamcinolone—hematologic cancer	0.000163	0.000918	CcSEcCtD
Ramelteon—Headache—Vincristine—hematologic cancer	0.000161	0.000908	CcSEcCtD
Ramelteon—Nausea—Carmustine—hematologic cancer	0.00016	0.000902	CcSEcCtD
Ramelteon—Nausea—Alitretinoin—hematologic cancer	0.000159	0.000894	CcSEcCtD
Ramelteon—Headache—Mitoxantrone—hematologic cancer	0.000157	0.000884	CcSEcCtD
Ramelteon—Headache—Irinotecan—hematologic cancer	0.000157	0.000884	CcSEcCtD
Ramelteon—Nausea—Ifosfamide—hematologic cancer	0.000157	0.000883	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000156	0.000881	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000156	0.000881	CcSEcCtD
Ramelteon—Arthralgia—Prednisone—hematologic cancer	0.000156	0.000878	CcSEcCtD
Ramelteon—Myalgia—Prednisone—hematologic cancer	0.000156	0.000878	CcSEcCtD
Ramelteon—Diarrhoea—Cisplatin—hematologic cancer	0.000156	0.000877	CcSEcCtD
Ramelteon—Insomnia—Betamethasone—hematologic cancer	0.000155	0.000874	CcSEcCtD
Ramelteon—Insomnia—Dexamethasone—hematologic cancer	0.000155	0.000874	CcSEcCtD
Ramelteon—Headache—Gemcitabine—hematologic cancer	0.000153	0.000862	CcSEcCtD
Ramelteon—Nausea—Vincristine—hematologic cancer	0.000153	0.000861	CcSEcCtD
Ramelteon—Dysgeusia—Methotrexate—hematologic cancer	0.00015	0.000844	CcSEcCtD
Ramelteon—Asthenia—Etoposide—hematologic cancer	0.00015	0.000843	CcSEcCtD
Ramelteon—Anaphylactic shock—Prednisone—hematologic cancer	0.000149	0.000842	CcSEcCtD
Ramelteon—Nausea—Mitoxantrone—hematologic cancer	0.000149	0.000839	CcSEcCtD
Ramelteon—Nausea—Irinotecan—hematologic cancer	0.000149	0.000839	CcSEcCtD
Ramelteon—Fatigue—Betamethasone—hematologic cancer	0.000148	0.000833	CcSEcCtD
Ramelteon—Fatigue—Dexamethasone—hematologic cancer	0.000148	0.000833	CcSEcCtD
Ramelteon—Nausea—Gemcitabine—hematologic cancer	0.000145	0.000817	CcSEcCtD
Ramelteon—Diarrhoea—Etoposide—hematologic cancer	0.000143	0.000804	CcSEcCtD
Ramelteon—Dysgeusia—Epirubicin—hematologic cancer	0.00014	0.00079	CcSEcCtD
Ramelteon—Dizziness—Etoposide—hematologic cancer	0.000138	0.000777	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000136	0.000767	CcSEcCtD
Ramelteon—Dizziness—Prednisolone—hematologic cancer	0.000136	0.000766	CcSEcCtD
Ramelteon—Asthenia—Triamcinolone—hematologic cancer	0.000136	0.000764	CcSEcCtD
Ramelteon—Nausea—Cisplatin—hematologic cancer	0.000135	0.000761	CcSEcCtD
Ramelteon—Insomnia—Prednisone—hematologic cancer	0.000135	0.000761	CcSEcCtD
Ramelteon—Headache—Etoposide—hematologic cancer	0.000131	0.000736	CcSEcCtD
Ramelteon—Myalgia—Methotrexate—hematologic cancer	0.00013	0.000734	CcSEcCtD
Ramelteon—Arthralgia—Methotrexate—hematologic cancer	0.00013	0.000734	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—hematologic cancer	0.00013	0.000731	CcSEcCtD
Ramelteon—Fatigue—Prednisone—hematologic cancer	0.000129	0.000726	CcSEcCtD
Ramelteon—Headache—Prednisolone—hematologic cancer	0.000129	0.000726	CcSEcCtD
Ramelteon—Dizziness—Triamcinolone—hematologic cancer	0.000125	0.000704	CcSEcCtD
Ramelteon—Anaphylactic shock—Methotrexate—hematologic cancer	0.000125	0.000703	CcSEcCtD
Ramelteon—Nausea—Etoposide—hematologic cancer	0.000124	0.000698	CcSEcCtD
Ramelteon—Asthenia—Betamethasone—hematologic cancer	0.000123	0.000693	CcSEcCtD
Ramelteon—Asthenia—Dexamethasone—hematologic cancer	0.000123	0.000693	CcSEcCtD
Ramelteon—Nausea—Prednisolone—hematologic cancer	0.000122	0.000688	CcSEcCtD
Ramelteon—Myalgia—Epirubicin—hematologic cancer	0.000122	0.000687	CcSEcCtD
Ramelteon—Arthralgia—Epirubicin—hematologic cancer	0.000122	0.000687	CcSEcCtD
Ramelteon—Headache—Triamcinolone—hematologic cancer	0.000119	0.000667	CcSEcCtD
Ramelteon—Diarrhoea—Dexamethasone—hematologic cancer	0.000117	0.000661	CcSEcCtD
Ramelteon—Diarrhoea—Betamethasone—hematologic cancer	0.000117	0.000661	CcSEcCtD
Ramelteon—Anaphylactic shock—Epirubicin—hematologic cancer	0.000117	0.000658	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000114	0.000641	CcSEcCtD
Ramelteon—Dizziness—Betamethasone—hematologic cancer	0.000114	0.000639	CcSEcCtD
Ramelteon—Dizziness—Dexamethasone—hematologic cancer	0.000114	0.000639	CcSEcCtD
Ramelteon—Insomnia—Methotrexate—hematologic cancer	0.000113	0.000636	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—hematologic cancer	0.000113	0.000635	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—hematologic cancer	0.000113	0.000635	CcSEcCtD
Ramelteon—Nausea—Triamcinolone—hematologic cancer	0.000112	0.000633	CcSEcCtD
Ramelteon—Somnolence—Methotrexate—hematologic cancer	0.000111	0.000625	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000108	0.000609	CcSEcCtD
Ramelteon—Fatigue—Methotrexate—hematologic cancer	0.000108	0.000606	CcSEcCtD
Ramelteon—Headache—Betamethasone—hematologic cancer	0.000108	0.000605	CcSEcCtD
Ramelteon—Headache—Dexamethasone—hematologic cancer	0.000108	0.000605	CcSEcCtD
Ramelteon—Asthenia—Prednisone—hematologic cancer	0.000107	0.000604	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000107	0.0006	CcSEcCtD
Ramelteon—Insomnia—Epirubicin—hematologic cancer	0.000106	0.000595	CcSEcCtD
Ramelteon—Somnolence—Epirubicin—hematologic cancer	0.000104	0.000585	CcSEcCtD
Ramelteon—Diarrhoea—Prednisone—hematologic cancer	0.000102	0.000576	CcSEcCtD
Ramelteon—Nausea—Betamethasone—hematologic cancer	0.000102	0.000574	CcSEcCtD
Ramelteon—Nausea—Dexamethasone—hematologic cancer	0.000102	0.000574	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—hematologic cancer	0.000101	0.000568	CcSEcCtD
Ramelteon—Dizziness—Prednisone—hematologic cancer	9.89e-05	0.000557	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.86e-05	0.000555	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—hematologic cancer	9.78e-05	0.000551	CcSEcCtD
Ramelteon—Somnolence—Doxorubicin—hematologic cancer	9.62e-05	0.000542	CcSEcCtD
Ramelteon—Headache—Prednisone—hematologic cancer	9.37e-05	0.000527	CcSEcCtD
Ramelteon—Fatigue—Doxorubicin—hematologic cancer	9.33e-05	0.000525	CcSEcCtD
Ramelteon—Asthenia—Methotrexate—hematologic cancer	8.96e-05	0.000505	CcSEcCtD
Ramelteon—Nausea—Prednisone—hematologic cancer	8.88e-05	0.0005	CcSEcCtD
Ramelteon—Diarrhoea—Methotrexate—hematologic cancer	8.55e-05	0.000481	CcSEcCtD
Ramelteon—Asthenia—Epirubicin—hematologic cancer	8.39e-05	0.000472	CcSEcCtD
Ramelteon—Dizziness—Methotrexate—hematologic cancer	8.26e-05	0.000465	CcSEcCtD
Ramelteon—Diarrhoea—Epirubicin—hematologic cancer	8e-05	0.00045	CcSEcCtD
Ramelteon—Headache—Methotrexate—hematologic cancer	7.83e-05	0.000441	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—hematologic cancer	7.76e-05	0.000437	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—hematologic cancer	7.73e-05	0.000435	CcSEcCtD
Ramelteon—Nausea—Methotrexate—hematologic cancer	7.42e-05	0.000418	CcSEcCtD
Ramelteon—Diarrhoea—Doxorubicin—hematologic cancer	7.4e-05	0.000417	CcSEcCtD
Ramelteon—Headache—Epirubicin—hematologic cancer	7.32e-05	0.000412	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—hematologic cancer	7.15e-05	0.000403	CcSEcCtD
Ramelteon—Nausea—Epirubicin—hematologic cancer	6.95e-05	0.000391	CcSEcCtD
Ramelteon—Headache—Doxorubicin—hematologic cancer	6.78e-05	0.000382	CcSEcCtD
Ramelteon—Nausea—Doxorubicin—hematologic cancer	6.43e-05	0.000362	CcSEcCtD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.3e-05	0.00019	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.29e-05	0.000188	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—JAK2—hematologic cancer	2.28e-05	0.000188	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—JAK2—hematologic cancer	2.28e-05	0.000188	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CDA—hematologic cancer	2.24e-05	0.000185	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CA—hematologic cancer	2.24e-05	0.000184	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CA—hematologic cancer	2.24e-05	0.000184	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MDM2—hematologic cancer	2.23e-05	0.000183	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MDM2—hematologic cancer	2.23e-05	0.000183	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CB—hematologic cancer	2.17e-05	0.000178	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MTOR—hematologic cancer	2.17e-05	0.000178	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CB—hematologic cancer	2.17e-05	0.000178	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MTOR—hematologic cancer	2.17e-05	0.000178	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PC—hematologic cancer	2.16e-05	0.000178	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.15e-05	0.000177	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.1e-05	0.000173	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GBA—hematologic cancer	2.09e-05	0.000172	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC35B2—hematologic cancer	2.09e-05	0.000172	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HRAS—hematologic cancer	2.07e-05	0.00017	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HRAS—hematologic cancer	2.07e-05	0.00017	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN1B—hematologic cancer	2.03e-05	0.000168	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN1B—hematologic cancer	2.03e-05	0.000168	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—DCK—hematologic cancer	2.02e-05	0.000166	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—B3GAT1—hematologic cancer	2.02e-05	0.000166	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ASNS—hematologic cancer	2.02e-05	0.000166	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AKT1—hematologic cancer	2.01e-05	0.000166	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AKT1—hematologic cancer	2.01e-05	0.000166	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CASP3—hematologic cancer	1.99e-05	0.000164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CASP3—hematologic cancer	1.99e-05	0.000164	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—hematologic cancer	1.99e-05	0.000164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2—hematologic cancer	1.99e-05	0.000164	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—hematologic cancer	1.98e-05	0.000163	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—hematologic cancer	1.98e-05	0.000163	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.97e-05	0.000162	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GMPS—hematologic cancer	1.95e-05	0.00016	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PHYH—hematologic cancer	1.95e-05	0.00016	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FTCD—hematologic cancer	1.95e-05	0.00016	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—hematologic cancer	1.94e-05	0.00016	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—hematologic cancer	1.94e-05	0.00016	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—JUN—hematologic cancer	1.94e-05	0.000159	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—JUN—hematologic cancer	1.94e-05	0.000159	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HDC—hematologic cancer	1.91e-05	0.000157	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTAP—hematologic cancer	1.91e-05	0.000157	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN1A—hematologic cancer	1.88e-05	0.000155	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.88e-05	0.000155	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTEN—hematologic cancer	1.87e-05	0.000154	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTEN—hematologic cancer	1.87e-05	0.000154	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK8—hematologic cancer	1.83e-05	0.000151	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK8—hematologic cancer	1.83e-05	0.000151	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AKT1—hematologic cancer	1.83e-05	0.00015	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AKT1—hematologic cancer	1.83e-05	0.00015	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EP300—hematologic cancer	1.79e-05	0.000147	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EP300—hematologic cancer	1.79e-05	0.000147	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.78e-05	0.000147	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.78e-05	0.000147	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CDA—hematologic cancer	1.75e-05	0.000144	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SRC—hematologic cancer	1.74e-05	0.000143	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SRC—hematologic cancer	1.74e-05	0.000143	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—FHL2—hematologic cancer	1.7e-05	0.00014	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—hematologic cancer	1.69e-05	0.000139	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—hematologic cancer	1.69e-05	0.000139	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PC—hematologic cancer	1.68e-05	0.000139	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STAT3—hematologic cancer	1.68e-05	0.000138	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STAT3—hematologic cancer	1.68e-05	0.000138	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NRAS—hematologic cancer	1.67e-05	0.000138	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NRAS—hematologic cancer	1.67e-05	0.000138	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AGRN—hematologic cancer	1.67e-05	0.000137	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.63e-05	0.000134	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GBA—hematologic cancer	1.63e-05	0.000134	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK3—hematologic cancer	1.6e-05	0.000132	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK3—hematologic cancer	1.6e-05	0.000132	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—IDH2—hematologic cancer	1.58e-05	0.00013	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HMMR—hematologic cancer	1.58e-05	0.00013	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DCK—hematologic cancer	1.56e-05	0.000128	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ASNS—hematologic cancer	1.56e-05	0.000128	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.56e-05	0.000128	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—hematologic cancer	1.56e-05	0.000128	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—hematologic cancer	1.56e-05	0.000128	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TGFB1—hematologic cancer	1.55e-05	0.000128	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TGFB1—hematologic cancer	1.55e-05	0.000128	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.49e-05	0.000123	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTAP—hematologic cancer	1.49e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ARNTL—hematologic cancer	1.49e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HDC—hematologic cancer	1.48e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ACP5—hematologic cancer	1.45e-05	0.000119	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA9—hematologic cancer	1.45e-05	0.000119	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—hematologic cancer	1.44e-05	0.000118	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—hematologic cancer	1.44e-05	0.000118	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOR2—hematologic cancer	1.43e-05	0.000118	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—IDH1—hematologic cancer	1.36e-05	0.000112	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CDA—hematologic cancer	1.35e-05	0.000111	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCC3—hematologic cancer	1.34e-05	0.000111	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TXN—hematologic cancer	1.34e-05	0.000111	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTO1—hematologic cancer	1.34e-05	0.000111	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—FHL2—hematologic cancer	1.33e-05	0.000109	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.32e-05	0.000109	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CA—hematologic cancer	1.32e-05	0.000109	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SPHK1—hematologic cancer	1.32e-05	0.000108	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AGRN—hematologic cancer	1.3e-05	0.000107	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PC—hematologic cancer	1.3e-05	0.000107	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—hematologic cancer	1.28e-05	0.000105	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—hematologic cancer	1.28e-05	0.000105	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—UGT1A1—hematologic cancer	1.26e-05	0.000104	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.26e-05	0.000103	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GBA—hematologic cancer	1.26e-05	0.000103	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—IDH2—hematologic cancer	1.23e-05	0.000101	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HMMR—hematologic cancer	1.23e-05	0.000101	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC22A1—hematologic cancer	1.23e-05	0.000101	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CRABP1—hematologic cancer	1.23e-05	0.000101	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRAS—hematologic cancer	1.22e-05	0.000101	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRAS—hematologic cancer	1.22e-05	0.000101	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALOX5—hematologic cancer	1.2e-05	9.87e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—hematologic cancer	1.17e-05	9.63e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—hematologic cancer	1.17e-05	9.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.16e-05	9.57e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NUP98—hematologic cancer	1.16e-05	9.56e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.16e-05	9.54e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTAP—hematologic cancer	1.15e-05	9.45e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA9—hematologic cancer	1.13e-05	9.28e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACP5—hematologic cancer	1.13e-05	9.28e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA3—hematologic cancer	1.13e-05	9.28e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ADCY7—hematologic cancer	1.13e-05	9.28e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NUP214—hematologic cancer	1.12e-05	9.21e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.11e-05	9.16e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.11e-05	9.12e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTR—hematologic cancer	1.1e-05	9.03e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCG2—hematologic cancer	1.1e-05	9.03e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—hematologic cancer	1.08e-05	8.89e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—hematologic cancer	1.08e-05	8.89e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ENO2—hematologic cancer	1.08e-05	8.85e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—IDH1—hematologic cancer	1.06e-05	8.73e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.05e-05	8.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TXN—hematologic cancer	1.05e-05	8.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.05e-05	8.63e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—hematologic cancer	1.04e-05	8.59e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.03e-05	8.45e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SPHK1—hematologic cancer	1.03e-05	8.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FHL2—hematologic cancer	1.02e-05	8.42e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SDC1—hematologic cancer	1.02e-05	8.39e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AGRN—hematologic cancer	1e-05	8.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—UGT1A1—hematologic cancer	9.85e-06	8.11e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.74e-06	8.02e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.61e-06	7.91e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CRABP1—hematologic cancer	9.58e-06	7.89e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC22A1—hematologic cancer	9.58e-06	7.89e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HMMR—hematologic cancer	9.51e-06	7.83e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—IDH2—hematologic cancer	9.51e-06	7.83e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALOX5—hematologic cancer	9.34e-06	7.69e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.19e-06	7.57e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NUP98—hematologic cancer	9.05e-06	7.45e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.94e-06	7.36e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ADCY7—hematologic cancer	8.78e-06	7.23e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA3—hematologic cancer	8.78e-06	7.23e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NUP214—hematologic cancer	8.72e-06	7.18e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA9—hematologic cancer	8.7e-06	7.16e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACP5—hematologic cancer	8.7e-06	7.16e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NQO1—hematologic cancer	8.67e-06	7.14e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CD44—hematologic cancer	8.67e-06	7.14e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.63e-06	7.1e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.59e-06	7.07e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTR—hematologic cancer	8.54e-06	7.03e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCG2—hematologic cancer	8.54e-06	7.03e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.49e-06	6.99e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ENO2—hematologic cancer	8.38e-06	6.9e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYCS—hematologic cancer	8.2e-06	6.75e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—IDH1—hematologic cancer	8.18e-06	6.73e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	8.15e-06	6.71e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—hematologic cancer	8.13e-06	6.69e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.09e-06	6.66e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.09e-06	6.66e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TXN—hematologic cancer	8.09e-06	6.66e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8e-06	6.59e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SDC1—hematologic cancer	7.94e-06	6.54e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.91e-06	6.52e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.6e-06	6.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.59e-06	6.25e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.49e-06	6.17e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.4e-06	6.09e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.4e-06	6.09e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.33e-06	6.04e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—hematologic cancer	7.23e-06	5.95e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.21e-06	5.93e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.16e-06	5.9e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.99e-06	5.76e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NUP98—hematologic cancer	6.98e-06	5.75e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.84e-06	5.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.78e-06	5.58e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.78e-06	5.58e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CD44—hematologic cancer	6.75e-06	5.56e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NQO1—hematologic cancer	6.75e-06	5.56e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NUP214—hematologic cancer	6.73e-06	5.54e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—hematologic cancer	6.64e-06	5.47e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOR1—hematologic cancer	6.64e-06	5.47e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.61e-06	5.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTR—hematologic cancer	6.59e-06	5.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.59e-06	5.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ENO2—hematologic cancer	6.47e-06	5.32e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYCS—hematologic cancer	6.39e-06	5.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	6.35e-06	5.23e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.27e-06	5.16e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SDC1—hematologic cancer	6.13e-06	5.05e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.87e-06	4.83e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.71e-06	4.7e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.63e-06	4.64e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.45e-06	4.49e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.33e-06	4.39e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NQO1—hematologic cancer	5.21e-06	4.29e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CD44—hematologic cancer	5.21e-06	4.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOR1—hematologic cancer	5.18e-06	4.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—hematologic cancer	5.18e-06	4.26e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.17e-06	4.26e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.93e-06	4.06e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYCS—hematologic cancer	4.93e-06	4.06e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.9e-06	4.03e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.57e-06	3.77e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.57e-06	3.77e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.35e-06	3.58e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.34e-06	3.57e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALB—hematologic cancer	4.28e-06	3.52e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.11e-06	3.39e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3R1—hematologic cancer	4.09e-06	3.37e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.03e-06	3.32e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.99e-06	3.29e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.99e-06	3.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.84e-06	3.16e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.78e-06	3.11e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.56e-06	2.93e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.53e-06	2.91e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.38e-06	2.78e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALB—hematologic cancer	3.34e-06	2.75e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—hematologic cancer	3.27e-06	2.69e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.19e-06	2.63e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—EP300—hematologic cancer	3.11e-06	2.56e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.97e-06	2.44e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.94e-06	2.42e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.75e-06	2.26e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.61e-06	2.15e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALB—hematologic cancer	2.57e-06	2.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—hematologic cancer	2.54e-06	2.1e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.46e-06	2.03e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—EP300—hematologic cancer	2.43e-06	2e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.3e-06	1.9e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.27e-06	1.87e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—hematologic cancer	1.96e-06	1.62e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—hematologic cancer	1.88e-06	1.55e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—EP300—hematologic cancer	1.87e-06	1.54e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.8e-06	1.48e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—hematologic cancer	1.47e-06	1.21e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.39e-06	1.14e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—hematologic cancer	1.13e-06	9.32e-06	CbGpPWpGaD
